| Dr Kris-ann Shanique Humphrey, MD | |
|
790 Concourse Pkwy S Ste 200, Maitland, FL 32751-6114 | |
| (407) 767-6411 | |
| Not Available |
| Full Name | Dr Kris-ann Shanique Humphrey |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | 790 Concourse Pkwy S Ste 200, Maitland, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013302660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 146759 (Florida) | Secondary |
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 146759 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Pediatric Associates, Llc | 2567375561 | 25 |
News Archive
Merz Pharma Group today announced the successful completion of the $5.45 per share cash tender offer for all outstanding shares of BioForm Medical, Inc. made by Merz GmbH & Co. KGaA and its acquisition subsidiary. The tender offer expired at 12:00 midnight, Eastern Standard Time, on February 12, 2010.
Wanting to achieve early cancer detection, a group of scientists from the Center for Research in Optics (CIO) of Guadalajara, in Mexico, seeks to address the problem from the cell with optical radiation.
Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.
Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease's progression.
› Verified 8 days ago
| Entity Name | Florida Pediatric Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053346718 PECOS PAC ID: 2567375561 Enrollment ID: O20031106000599 |
News Archive
Merz Pharma Group today announced the successful completion of the $5.45 per share cash tender offer for all outstanding shares of BioForm Medical, Inc. made by Merz GmbH & Co. KGaA and its acquisition subsidiary. The tender offer expired at 12:00 midnight, Eastern Standard Time, on February 12, 2010.
Wanting to achieve early cancer detection, a group of scientists from the Center for Research in Optics (CIO) of Guadalajara, in Mexico, seeks to address the problem from the cell with optical radiation.
Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.
Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease's progression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kris-ann Shanique Humphrey, MD 790 Concourse Pkwy S, Maitland, FL 32751-6114 Ph: (407) 767-6411 | Dr Kris-ann Shanique Humphrey, MD 790 Concourse Pkwy S Ste 200, Maitland, FL 32751-6114 Ph: (407) 767-6411 |
News Archive
Merz Pharma Group today announced the successful completion of the $5.45 per share cash tender offer for all outstanding shares of BioForm Medical, Inc. made by Merz GmbH & Co. KGaA and its acquisition subsidiary. The tender offer expired at 12:00 midnight, Eastern Standard Time, on February 12, 2010.
Wanting to achieve early cancer detection, a group of scientists from the Center for Research in Optics (CIO) of Guadalajara, in Mexico, seeks to address the problem from the cell with optical radiation.
Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.
Technology being developed at Washington State University provides a non-invasive approach for diagnosing prostate cancer and tracking the disease's progression.
› Verified 8 days ago
Dr. Lynda Z Kleiman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 790 Concourse Pkwy S Ste 200, Maitland, FL 32751 Phone: 407-767-6411 Fax: 407-767-8160 | |
Dr. Robert S Gold, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 790 Concourse Pkwy S, Suite 200, Maitland, FL 32751 Phone: 407-767-6411 Fax: 407-767-8160 | |
Dr. Jerry N Shuster, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 790 Concourse Pkwy S, Suite 200, Maitland, FL 32751 Phone: 407-767-6411 Fax: 407-767-8160 | |
Dr. David B Auerbach, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 790 Concourse Pkwy S, Suite 200, Maitland, FL 32751 Phone: 407-767-6411 Fax: 407-767-8160 | |
Andrew Aziz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 331 N Maitland Ave, Ste B2, Maitland, FL 32751 Phone: 407-740-0331 Fax: 407-539-2747 | |
Hamza Muhammad Pasha, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 790 Concourse Pkwy S Ste 200, Maitland, FL 32751 Phone: 407-767-6411 |